HYPERLIQUID STRATEGIES INC (PURR)
NASDAQFinancialsFinancial - Capital MarketsSnapshot 2026-09-04
$12.18-4.62%
Close 2026-09-04 · 1-day change
NASDAQFinancialsFinancial - Capital MarketsSnapshot 2026-09-04
QuarterlyIQ Insights · PURR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -19.1% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 189 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name has erratic recent earnings surprises and missed its most recent quarter. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 27 industry peers · Company calendar date is not available
PURR — earnings miss
Dated 2026-08-27
Results of Operations and Financial Condition. On August 27, 2026, Hyperliquid Strategies Inc (the “Company”) issued a press release announcing its financial results for the fiscal year ended June 30, 2026. A copy of the press release is included as Exhibit 99.1 to this report. The information in this report under this item, including the exhibit, is provided under
Why it matters: If earnings beat expectations, it will help the positive trend from the recent earnings news.
Supportive ifEarnings for Q1 2026 confirm the positive trend with a beat of at least 5% over consensus estimates.
Worry ifEarnings for Q1 2026 miss consensus estimates by more than 5%.
Why it matters: Finishing this process shows Hyperliquid cares about digital assets. It can help their finances.
Supportive ifAnnouncement about the last steps of the bio-tech sale.
Worry ifMore delays or problems with the bio-tech sale.
Why it matters: HYPE token price impacts the company's balance sheet and overall financial health.
Watch forHYPE token price goes above $36.60, raising asset value a lot.
Also watch forHYPE token price falls below $30.00, hurting the balance sheet.
Why it matters: A higher net profit shows strong performance. It also shows good money management.
Supportive ifNet profit goes over $152.5 million in Q2 2026. This confirms strong performance.
Worry ifNet profit drops below $152.5 million. This suggests possible problems in operations.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$423 on $10,000 · ±4.2% | How much price usually moves either way. |
| Bad day | $928 loss on $10,000 · 9.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,558 loss on $10,000 · 45.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Stable prices above $60 show strong market trust in the HYPE token.
Supportive ifHYPE token price stays above $60 for two months in a row.
Worry ifHYPE token price falls below $60 and stays there.
Why it matters: A drop in revenue growth could signal a slowdown in the financial sector. This would impact investor confidence in Hyperliquid Strategies.
Worry ifRevenue growth for Q1 2026 falls below the median of the last three years.
Less concerning ifRevenue growth for Q1 2026 stays above the median of the last three years.
Why it matters: Keeping positive net income shows strong performance and good cost control.
Supportive ifNet income is positive for the quarter ending September 30, 2026.
Worry ifNet income turns negative for the quarter.
Why it matters: A drop in revenue growth could signal a slowdown in the financial sector.
Worry ifRevenue growth drops below the median of 15% year over year.
Less concerning ifRevenue growth remains above the median of 15% year over year.
Why it matters: More HYPE token holdings show strong use of money. This helps long-term value.
Supportive ifHYPE token treasury grows to over 30 million tokens by the next earnings report.
Worry ifHYPE token treasury fails to grow or declines from current levels.
Why it matters: Higher staking revenue shows good use of HYPE holdings. This helps make more money.
Supportive ifStaking revenue exceeds $10 million in the next fiscal quarter.
Worry ifStaking revenue declines or stays below $9 million.
Why it matters: Finishing this exit lets focus on digital asset plans. It also helps use money better.
Supportive ifManagement will confirm full exit from old biotech work in the next earnings report.
Worry ifManagement says there are delays or problems in leaving the biotech business.